[Mononeuritis multiplex under the TNF-alpha inhibitor infliximab]. / Mononeuritis multiplex unter dem TNF-alpha-Hemmer Infliximab.
Praxis (Bern 1994)
; 100(4): 241-3, 2011 Feb 16.
Article
in De
| MEDLINE
| ID: mdl-21328239
ABSTRACT
A 21-year-old patient with ankylosing spondylitis under treatment with the TNF-alpha inhibitor infliximab developed a multifocal, demyelinating axonal neuropathy affecting several peripheral nerves simultaneously (mononeuritis multiplex). This represents an additional rare peripheral nervous system side effect of infliximab therapy. The underlying cause is unknown. Intravenous immunoglobulin therapy (0.4 g/kg per day for five days) led to a complete regression of muscle paresis and sensory defects in this case.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Spondylitis, Ankylosing
/
Anti-Inflammatory Agents
/
Antibodies, Monoclonal
Type of study:
Diagnostic_studies
Limits:
Adult
/
Humans
/
Male
Language:
De
Journal:
Praxis (Bern 1994)
Year:
2011
Document type:
Article